SOURCE: Laidlaw & Co.

October 02, 2013 08:30 ET

Laidlaw & Company (UK) LTD Hires Doctor Yale Jen as Managing Director, Healthcare Research

Continues Expansion of Healthcare Research Team

NEW YORK, NY--(Marketwired - Oct 2, 2013) - Laidlaw & Co. (UK) LTD ("Laidlaw") is proud to announce the expansion of its Healthcare Research Team with the addition of Yale Jen, Ph.D. as Managing Director.

Dr. Jen joins Laidlaw from Roth Capital where he was a senior equity research analyst focusing on the biotechnology sector. Prior to Roth Capital, he held senior and associate analyst positions, respectively, with Maxim Group, Rodman & Renshaw and Thomas Weisel Partners. His investment views have been cited in The Wall Street Journal, Bloomberg, Thomson Reuters and Dow Jones Newswires. Prior to joining Wall Street, Dr. Jen spent several years with KPMG Corporate Finance Life Sciences Group and Genesis Group Associates focusing on mergers and acquisitions and pipeline optimization for pharmaceutical and biotechnology clients. Dr. Jen holds a Ph.D. in molecular biology from Cornell Medical School and an MBA from Rutgers University.

Laidlaw Chief Executive Officer Matthew Eitner said, "We are very pleased that Dr. Jen has joined Laidlaw & Company, expanding our healthcare research capabilities with an experienced veteran in the healthcare space. His track record of uncovering value and successful companies in the biotechnology and life sciences space makes him an ideal fit for Laidlaw as we expand our firm."

Dr. Jen resides in Bergen County, New Jersey with his wife and two children. He is an avid reader and classical movie aficionado.

About Laidlaw & Co. (UK) Ltd.

Laidlaw & Company (UK) Ltd, founded in 1842, is a relationship driven international investment bank, providing wealth management services, capital raising, mergers & acquisitions advisory, research and corporate access to clients on a global level. Headquartered in New York City and United Kingdom, Laidlaw maintains eight offices across the United States and London, England with over 150 employees firm wide. Laidlaw also offers personalized investment advice and skillful execution to private and public institutions, as well as high net worth individual investors.  The firm is a FINRA, MSRB and SIPC registered company.

Contact Information

  • Contact:
    Bryan Kobel
    Vice President, Capital Markets
    Laidlaw & Company (UK) Ltd.
    Phone: 212-953-4900
    Email: Email Contact